How does the UPLIFT study relate to tiotropium?

UPLIFT is the name of one of the largest clinical studies of the effect of tiotropium in people with chronic obstructive pulmonary disease (COPD). It stands for Understanding the Potential Long-term Impacts on Function with Tiotropium.

UPLIFT examined the health of 6,000 participants with COPD who took tiotropium (Spiriva HandiHaler) over several years. Results showed that tiotropium helped improve lung function for up to four years.

Continue Learning about Antiasthma

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.